Works by Mohyuddin, Ghulam Rehman


Results: 68
    1
    2
    3

    Evaluating early intervention in smoldering myeloma clinical trials: a systematic review.

    Published in:
    Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae219
    By:
    • Kakkilaya, Apoorva;
    • Trando, Aaron;
    • Cliff, Edward R Scheffer;
    • Mian, Hira;
    • Hadidi, Samer Al;
    • Aziz, Muhammad;
    • Goodman, Aaron M;
    • Jeong, Ah-Reum;
    • Smith, Wade L;
    • Kelkar, Amar H;
    • Russler-Germain, David A;
    • Mehra, Nikita;
    • Chakraborty, Rajshekhar;
    • Gertz, Morie A;
    • Mohyuddin, Ghulam Rehman
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Financial toxicity in hematological malignancies: a systematic review.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00671-z
    By:
    • Ouchveridze, Evguenia;
    • Banerjee, Rahul;
    • Desai, Aakash;
    • Aziz, Muhammad;
    • Lee-Smith, Wade;
    • Mian, Hira;
    • Berger, Katherine;
    • McClune, Brian;
    • Sborov, Douglas;
    • Qazilbash, Muzaffar;
    • Kumar, Shaji;
    • Mohyuddin, Ghulam Rehman
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center.

    Published in:
    2018
    By:
    • Mohyuddin, Ghulam Rehman;
    • Faisal, Muhammad Salman;
    • Badar, Talha;
    • Shah, Nina;
    • Bashir, Qaiser;
    • Patel, Krina K.;
    • Hosing, Chitra;
    • Popat, Uday R.;
    • Rondon, Gabriela;
    • Delgado, Ruby;
    • Shah, Jatin J.;
    • Weber, Donna M.;
    • Thomas, Sheeba K.;
    • Manasanch, Elisabet E.;
    • Orlowski, Robert Z.;
    • Champlin, Richard E.;
    • Qazilbash, Muzaffar H.
    Publication type:
    Letter to the Editor
    31
    32

    Dietary interventions in cancer: a systematic review of all randomized controlled trials.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 7, p. 1026, doi. 10.1093/jnci/djae051
    By:
    • Ilerhunmwuwa, Nosakhare Paul;
    • Khader, Abul Hasan Shadali Abdul;
    • Smith, Calvin;
    • Cliff, Edward R Scheffer;
    • Booth, Christopher M;
    • Hottel, Evevanne;
    • Aziz, Muhammad;
    • Lee-Smith, Wade;
    • Goodman, Aaron;
    • Chakraborty, Rajshekhar;
    • Mohyuddin, Ghulam Rehman
    Publication type:
    Article
    33
    34
    35

    Value in Myeloma Care: Myth or Reality.

    Published in:
    Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 206, doi. 10.1007/s11899-022-00669-1
    By:
    • Ouchveridze, Evguenia;
    • Berger, Katherine;
    • Mohyuddin, Ghulam Rehman
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors.

    Published in:
    Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00137-9
    By:
    • Baranda, Joaquina C.;
    • Mohyuddin, Ghulam Rehman;
    • Bur, Andrés M.;
    • Shnayder, Yelizaveta;
    • Sweeney, Kyle R.;
    • Kakarala, Kiran;
    • Prouty, Megan;
    • Pathak, Harsh;
    • Puri, Rajni;
    • Mitra, Amrita;
    • Madan, Rashna;
    • Forrest, M. Laird;
    • Huang, Aric;
    • Weir, Scott;
    • Godwin, Andrew K.;
    • Alhakamy, Nabil A.;
    • Griffin, J. Daniel;
    • Berkland, Cory J.
    Publication type:
    Article
    48
    49
    50